MR Imaging of Perinatal Brain Injury

NCT ID: NCT02008045

Last Updated: 2026-01-13

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 557 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2009-07-01
• Study Completion Date: 2025-06-02

Brief Summary

The purpose of this study is to collect and compare information from cranial ultrasounds, magnetic resonance imaging scans, neurological exam and neuropsychological assessments of children. The investigators hope that the information collected in this study will help with early screening, diagnosis and treatment of brain injury in newborns as well as identify a connection between MR imaging (MRI-magnetic resonance imaging, MRS-magnetic resonance spectroscopy) and neurodevelopmental outcome.

Detailed Description

In the last two decades, major advances have been made in the clinical care of premature and term infants, including in the management of sepsis and respiratory compromise that can contribute to neurological disabilities in survivors. The incidence of classic cystic periventricular leukomalacia (PVL) has declined and a more diffuse and non-cystic pattern of cerebral white matter injury is more predominant. Although multiple pathologies occur in premature infants, the principal variety accounting for the predominance of neurodevelopmental disability is PVL. This disability in very low birth weight infants (VLBW) (< 1500 grams) includes cognitive/behavioral deficits in 25-50% and cerebral palsy in 5-10%. Neuroimaging studies of VLBW survivors suggest that the cerebral palsy is related to the focal necrotic lesions of PVL, whereas the cognitive/behavioral deficits correlate with more diffuse cerebral white matter injury. PVL is defined as damaged immature cerebral white matter with periventricular focal necrosis ("focal" component) in association with diffuse reactive gliosis and microglial activation in the surrounding white matter ("diffuse" component). Of note, PVL occurs in the late preterm infant and the term infant, particularly in cases of congenital heart disease. The pathogenesis of perinatal white matter injury is currently thought to be related to a complex interaction between maternal/fetal infection, cytokines and hypoxia-ischemia which results in both the generation of reactive oxygen specific agents (oxidative stress), apoptotic oligodendrocyte cell death, and axonal injury. In long-term survivors with PVL, neuroimaging studies often demonstrate reduced cerebral white matter volume, impaired myelination, ventriculomegaly and reduced volume in the cerebral cortex, thalamus/basal ganglia and cerebellum. In many of these long-term studies, the preterm children studies had normal cranial ultrasound. Cranial ultrasound, however, is not adequate for assessing non-cystic focal or diffuse white matter injury. To date, there are no longitudinal MR studies of preterm or congenital heart disease infants which correlate advanced neonatal MR imaging techniques with long-term neurodevelopmental outcome or advanced MR techniques performed in the childhood period.

Conditions

Perinatal White Matter Brain Injury

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Neonates at Risk for Brian Injury

Magnetic Resonance Imaging Neurodevelopmental Testing - 18 Month

Magnetic Resonance Imaging

Intervention Type: DEVICE

Brain MRI without Contrast

Neurodevelopmental Testing

Intervention Type: BEHAVIORAL

Validated battery of neurodevelopmental and psychological tests.

Term Neonates

Magnetic Resonance Imaging Neurodevelopmental Testing - 18 Month

Magnetic Resonance Imaging

Intervention Type: DEVICE

Brain MRI without Contrast

Neurodevelopmental Testing

Intervention Type: BEHAVIORAL

Validated battery of neurodevelopmental and psychological tests.

Interventions

Magnetic Resonance Imaging

Brain MRI without Contrast

Intervention Type: DEVICE

Neurodevelopmental Testing

Validated battery of neurodevelopmental and psychological tests.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Preterm babies and neonates with congenital heart disease
• Term Neonates

Exclusion Criteria

• Severe congenital brain malformation
• Significant chromosomal abnormality / syndrome which could confound the neurodevelopmental follow up data
• Preterm birth and congenital heart disease
• Focal neurological abnormality
• Chronic seizures
• Severe congenital brain malformation
• Significant chromosomal abnormality/ syndrome which could confound the neurodevelopmental follow up data
• Major pregnancy complication (diabetes, eclampsia)
• Sepsis
• ECMO
• Significant birth trauma and/or hypoxic ischemic injury

• Minimum Eligible Age: 1 Day
• Maximum Eligible Age: 7 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Pittsburgh

OTHER

Sponsor Role: lead

Responsible Party

Rafael Ceschin

Assistant Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Ashok Panigrahy, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pittsburgh

Locations

Children's Hospital of Pittsburgh of UPMC

Pittsburgh, Pennsylvania, United States

Countries

United States

Other Identifiers

STUDY19100215

Identifier Type: -

Identifier Source: org_study_id